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The major histocompatibility complex (H-2) of the mouse consists of four regions: 
H-2K, It, Ss, and H-2D (1). The H-2K and H-2D region genes code for cell-surface 
antigens (H-2 antigens) involved in production of typical H-2 antibodies and in graft 
rejection. The  Ss region codes for certain protein antigens in  the  serum  of normal 
mice  (2).  The Ir region has been associated with at least three different functions: 
It controls the level of antibody response to certain synthetic polypeptides (and prob- 
ably also to a variety of other antigens) (3, 4) ; it determines the degree of stimulation 
in mixed lymphocyte culture (MLC) (5) ; and it also determines the degree of graft-vs.- 
host (GVH) reaction (6). Differences in the Ir region, in at least some instances, do 
not lead to skin graft rejection (6). Until recently, the products of the Ir region have 
not been detected serologic.aNy.  In the present communication, we describe an anti- 
serum that seems to be directed against an antigen controlled by the Ir k region of the 
1t-2  a chromosome. The antigen is present only on thymus-derived (T) lymphocytes. 
Materials and Methods 
Mice were obtained from the Jackson Laboratory, Bar Harbor, Maine, or from the colonies 
at the University of Michigan (B10.HTT,  A.TE, AQR, and B10.K)  and the  Scripps Clinic 
and  Research Foundation (B10.A/SgSn,  A.SW/Sn, C3H/Sr, CBA/J, and A/J). B10.A(4R) 
mice were kindly provided by Dr. J. H. Stimptling,  McLaughlin Research  Institute, Great 
Falls, Mont. Nude mice bred onto the background of CBA (H-2 k) were a gift of Dr. M. B. 
A. Oldstone,  Scripps Clinic and Research  Foundation. Adult thymectomized, bone marrow- 
reconstituted A/J mice were prepared and kindly provided by Dr. J. Louis, Scripps Clinic. 
We refer to the four regions on the H-2 chromosome  (H-gK, Ir, Ss, and H-gD, in that 
order) with four small letters, indicating the genetic origin of these regions. For instance,  the 
H-2  a chromosome carried by strain B10.A is designated kkdd; it has the H-2K and Ir regions 
derived from  the H-2  ~ chromosome,  and the Ss and H-2D regions  derived from  the tt-g a 
chromosome. 
Antlsera.--Soluble  lymphocyte membrane antigens (SLMA)  were prepared by 3 M KC1 
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extraction (7) from spleen cells of B10.A mice, and injected into three groups of B10.D2 mice. 
In the first group (A), the mice received subcutaneous injections of 0.1 mg per mouse of SLMA 
once a week for 5 wk. In the second group (B), the five injections of the antigen were accom- 
partied by an intraperitoneal injection of polyadenylic-uridylic acid, poly A-U, (Miles Labora- 
tories, Kankakee, Ill.), 1 #tool nucleotide phosphorus per mouse. In the third group (C), each 
mouse received 0.2 mg of SLMA subcutaneously and 25 mg of endotoxin (ET)  (Escherichia 
¢oli lipopolysaccharide W of 0111:B4, lot 573564, Difco Laboratories, Detroit,  Mich.) intra- 
venously; 3 wk later the mice were boosted with a subcutaneous injection of 0.1 mg of SLMA 
and an intraperitoneal  injection of 12 mg of ET. All mice were bled before the first antigen 
injection and then weekly up to 7 wk. 
Lymphocytotoxic Tests.--The microtests under mineral oil with eosin as a dye and lymph 
node, spleen, thymus, or bone marrow lymphocytes as target  cells were performed as  de- 
scribed previously (7). Spleen and bone marrow lymphocytes were freed of contaminating  red 
cells by incubation in 10 ml of 0.83% NH4CI per spleen or by separation on a Ficoll-Isopaque 
gradient (8). The latter procedure was also used to remove dead lymphocytes after incubation 
with anti-0 serum and complement. Purified spleen or lymph node T cells were obtained by 
Leuko-Pak  filtration  (Julius  and  Herzenberg, personal  communication).  Normal  rabbit 
serum, selected for lack of nonspecific cytotoxicity, or agarose-absorbed guinea pig serum 
served as source of complement. Goat antibrain serum was kindly supplied by Dr. J. Clagett 
and AKR-anti-C3H  serum by Dr. J.  Chiller, Scripps Clinic; both  sera reacted identically 
with  thymocytes and purified T  cells. A two-stage lymphocytotoxic test was performed as 
described elsewhere (7). All serologic results described in this paper were obtained by both 
one- and two-stage cytotoxic tests. 
Absorptions were carried out as described earlier (7). 200,000 T cells purified from lymph 
nodes of B10.A mice completely abolished the cytotoxieity of  1 /zl of antiserum. This cell 
concentration was, therefore, routinely employed. 
RESULTS 
Cytotoxic antibodies were detected 6-15 days after the first antigen injection 
in the sera of all three groups of Bi0.D2 mice immunized with B10.A SLMA. 
The strongest of nine cytotoxic antisera (86°2) was obtained 19 days after the 
first  antigen injection with  ET  as  adjuvant. This  antiserum has  been used 
primarily throughout this study. 
Unlike H-2 alloantisera that usually kill 100% of the target cells, the antisera 
used in the present studies exhibited a reproducible cytotoxicity of only 20-25 % 
above background with a  titer range of  1:10 to  1:32, depending on the anti- 
serum used. The sera were cytotoxic for B10.A lymphocytes from spleen and 
lymph nodes but not for B10.A lymphocytes from thymus and bone marrow 
or for any type of lymphocytes of B10.D2, BI0, B10.M, A.SW, and DBA/1. 
This restricted reactivity suggested that the sera contained antibodies directed 
against antigens present only on the surface of a subpopulafion of lymphocytes, 
namely the T  cells. This conclusion was strengthened by the results obtained 
using T  cell-deprived spleen or node lymphocyte populations. T  cell elimination 
was achieved by (a)  treatment of a  B10.A cell suspension with anti-0 serum 
plus complement; (b)  thymectomy of A/J mice at the age of 6  wk, lethal ir- 
radiation  5  wk  later,  and  reconstitution with  15  ><  10  ~ anti-0 serum plus 
complement-treated bone marrow cells; (c) using spleen cells of nude mice bred GOTZE, REISFELD, KLEIN  BRIEF DEFINITIVE REPORT  I005 
to the background of CBA mice. None of these three cell populations reacted 
with the B10.D2 anti-B10.A sera. In contrast, augmentation by purification on 
a Leuko-Pak filter of the percentage of T cells to 85-95 % in the spleen or lymph 
node cell suspension elevated the cytotoxic effectiveness of these sera to 40-45 % 
above background. 
To determine the strain distribution of the antigen detected by the B10.D2 
anti-B 10.A-SLMA antibodies, the antisera were reacted against a panel of cells 
from selected mouse lines. The pattern of reactivity obtained with antiserum 
86-2 is depicted in Table I. The other eight antisera gave similar results. The 
TABLE I 
Cytotoxic Reactivity of BIO.D2 Anti-BlO.A  (86-2) Serum 
H-2  H-2 regions 
Strains  chromo-  Hybrid  Reactivity* 
some  H-2  maximal  killing 
symbols  K  Ir  Ss  D 
% 
B10.D2  d  --  d  d  d  d  <5  - 
B10.A  a  d/k  k  k  ]*  d  d  40  + 
BI0.K  k  --  k  k  k  k  40  + 
CBA  k  --  k  k  k  k  40  + 
B10  b  --  b  b  b  b  <5  -- 
B10.M  f  --  f  f  f  f  <5  -- 
B10.A(2R)  he  a/b  k  k  d  ~  b  30  + 
B10.A(4R)  hd  a/b  k  k/b  b  b  <10  - 
B10.A(5R)  ic  a/b  b  b  [  d  d  _-<10  - 
BI0.BR  k  --  k  k  k  k  25  + 
C3H  k  --  k  k  k  k  45  + 
DBA/I  q  --  q  q  q  q  <5  -- 
A.SW  s  --  s  s  s  s  <5  -- 
B10.HTT  tl  al/s  s  ]  k  k  d  25  + 
A.TE  te  tl/f  s  k  k  f  30  + 
AQR  ya  a/q  q  [  k  d  d  30  + 
* Percent maximal killing of purified lymph  node T  cells  (90% 0  positive)  =  percent killed cells with anti- 
serum  -  percent  killed cells without antiserum. 
:~ Vertical bars indicate the position of crossovers  (1). 
cytotoxicity of the  antiserum  against  cells of  the  recombinant strains  AQR 
(qkdd), A.TE (skkf), and B10.HTT (skkd) indicates that H-2 antigens are not 
responsible for the observed reactions. Cells of these strains do not share the 
H-2K  k allele with  the B10.A  (kkdd)  mice, i.e.,  the donor of the immunizing 
antigen.  Cells  from  mice  sharing  H-2K  or  H-2D  regions  with  these  three 
recombinants, specifically A.SW (ssss), DBA/1  (qqqq), and B10.M (ffff), were 
not killed by the serum. In addition,  cells of B10.A(4R)  (kk/bbb)  mice were 
not killed by the serum although these cells carry the same H-2K region antigen 
as  B10.A.  Thus,  apparently,  no  antibodies  were present  that  were directed 
against defined H-2 antigens. The testing of the antiserum, however, revealed 
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the Ss, since  the serum killed cells of all strains that share the Ir region with 
B10.A mice, i.e., B10.A (kkdcl),  B10.BR,  B10.K, C3H (all three have kkkk), 
B10.A(2R)  (kkdb),  B10.HTT  (skkd),  A.TE (skkf),  and AQR (qkdd).  A  weak 
cytotoxic effect was also observed on cells of B10.A(5R) (bbdd). 
To prove whether or not the antigens recognized by the antiserum in different 
recombinants  were  the  same,  absorptions  were  performed  with  B10.A, 
B10.A(2R),  B10.HTT,  A.TE,  AQR,  and  B10.A(4R)  cells.  The  results  are 
depicted in Fig. 1. Cells of B10.A, A.TE, AQR, and B10.A(2R) mice mutually 
absorbed the cytotoxicity of the serum, as did B10.HTT (not shown in Fig. 1). 
In contrast, no change of the cytotoxicity was observed after incubation with 
B10.A(4R) cells. 
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FIG.  1.  Absorptions of  B10.D2  anLi-B10.A-SLMA (86-2)  serum  with purified T  lymph 
node cells of the strains B10.A (O--O); A.TE (V--V); AQR (&--A); B10.A(2R) (l--~; 
and B10.A(4R)  (IN--I:]). The unabsorbed serum  (O--0)  and the absorbed samples were 
tested for remaining cytotoxicity against cells of B10.A, B10.A (2R), A.TE, and AQR. The 
letters below the target cells indicate the H-2 region symbols for the K-Ir-l-Ss/Slp-D regions. 
The boxes mark the identical parts of the H-2 complex for the four strains tested. B10.A(4R) 
is characterized as kk/bbb. 
DISCUSSION 
The sera utilized in the present studies reacted with products of genes located 
in  the  Ir  region  of  the  H-2  complex,  as  indicated  by  their  reaction  with 
B10.HTT, A.TE, AQR, B10.A, and B10.A(2R) but not B10.A(4R) cells. The 
best evidence for this conclusion is provided by the reaction pattern of the pair 
B10.A(2R) (kkdb) and B10.A(4R) (kk/bbb). Both strains were derived from the 
same parents by recombination within the H-2  complex. In  the B10.A(4R) 
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crossover took place between the Ss and H-2D regions (1). Thus, both strains 
differ only in the segment of the chromosome between the Ir and Ss regions. 
The B10.A(2R)  strain is identical for the Ir region with B10.A, and its cells 
were killed by the serum; the B10.A(4R) strain is different, and its cells were 
not killed. The B10.A(2R)  cells  are  known to  stimulate B10.A(4R)  cells  in 
MLC (5) and GVH reactions (6). 
It is highly suggestive that the antigen detected by the B10.D2 anti-B10.A- 
SLMA sera relates to structures influencing immune response. This hypothesis 
is supported by the following observations:  (a)  the close  linkage or identity 
with  Ir  genes known  to  control  the  immune  response  to  certain  synthetic 
polypeptide antigens (3) and immunoglobulin allotypes (4) ; (b) the presence of 
the antigen only on T  cells and in fact only on some of them; and (c) the ap- 
parent correlation of the reactivity of the antisera to MLC and GVH reactivity. 
The weaker reaction of the sera against B10.BR mice as compared with the 
reaction against B10.K mice might be an indication for Ir differences between 
B10.BR and B10.K. The weak reaction against B10.A(5R)  cells could be ex- 
plained if one assumed that the crossover took place closer  to the It-1 region 
in B10.A(SR) than in B10.A. Consequently, the B10.A(SR) strain would carry 
a part of the H-2  k chromosome between Ir-1  b and Ss  d. In fact, lymphocytes of 
B10.A(SR)  reduce the cytotxicity of the antiserum 86-2  against B10.A  cells 
but do not abolish it. This result indicates that the sera probably contain anti- 
bodies directed against at least two antigens and might suggest that there are 
at least two genes controlling the expression of these antigens. 
The solubilization procedure employed in this study apparently keeps the 
antigenic structures  controlled by the  Ir  region intact with respect  to  their 
immunogenicity. The fact that it is possible to raise cytotoxic antisera against 
such  antigens provides  a  valuable  tool for investigation of  the  biochemical 
and immunological nature of these antigens. 
An  antigen  of  notably  similar  properties  has  been  recently  studied  by 
Hauptfeld, Klein, and  Klein (9).  The  antigen was detected by a  B10.T(6R) 
anti-AQR antiserum that  reacted  only with  strains  carrying  the  Irk-region. 
The antigen, which seemed to be present only on T cells, was designated Ir-l.1. 
It is not clear whether the Ir-l.1 antigen is identical with the antigen detected 
with the B10.D2 anti-B10.A-SLMA and described in the present communica- 
tion, but the similarity between the two antigens is remarkable. 
SUMMARY 
Antibodies produced in B10.D2 mice against soluble lymphocyte membrane 
antigens of B10.A  (H-2  a)  mice reacted only with lymphocytes of the strains 
carrying  the  Ir  k region,  i.e.,  B10.A(2R),  B10.K,  B10.BR,  B10.HTT,  AQR, 
A.TE, C3H, and CBA; they did not react with cells of strains carrying different 
Ir regions, i.e., B10.A(4R),  B10, B10.M, A.SW, DBA/1. It is therefore con- 
cluded that the antigen detected with these antibodies is apparently controlled 1008  GOTZE,  REISFELD,  KLEIN  BRIEF  DEFINITIVE  REPORT 
by the [r region of the H-2 complex. The antigen is present on some T  lympho- 
cytes and absent on B  lymphocytes. Its presence or absence seems to correlate 
with MLC and GVH reactivity. 
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